Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-11-17 17:39:30
Reporting Period:
Accepted Time:
2020-11-17 17:39:30
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365619 Laura Brege C/o Pacira Biosciences, Inc.
5 Sylvan Way, Suite 300
Parsippany NJ 07054
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-16 12,000 $13.98 19,921 No 4 M Direct
Common Stock Disposition 2020-11-16 12,000 $65.95 7,921 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-11-16 12,000 $0.00 12,000 $13.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-06-02 No 4 M Direct
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.930 to $66.015, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The option vested and became exercisable in 24 equal monthly installments beginning on July 2, 2011.